Sirion Therapeutics, Inc. is a privately held biopharmaceutical company pursuing the discovery, development, and commercialization of products addressing unmet medical needs in the protection and preservation of eyesight. Sirion's diverse portfolio includes products that address ocular diseases and conditions including uveitis, herpetic keratitis, dry eye, glaucoma, and geographic atrophy associated with dry AMD.
View Top Employees from Sirion TherapeuticsWebsite | http://www.siriontherapeutics.com |
Revenue | $22 million |
Employees | 10 (10 on RocketReach) |
Address | 3963 Valley View Dr, Boston, Massachusetts 02127, US |
Phone | (813) 496-7325 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 38 Million |
Competitors | Alimera Sciences, Clearside Biomedical, Inc., Kala Pharmaceuticals, Ocular Therapeutix, Inc., Wellstat Management Company |
Looking for a particular Sirion Therapeutics employee's phone or email?
The Sirion Therapeutics annual revenue was $22 million in 2023.
10 people are employed at Sirion Therapeutics.
Sirion Therapeutics is based in Boston, Massachusetts.